We are live on ! Find out more
HUMA icon

Humacyte

83 hedge funds and large institutions have $48.7M invested in Humacyte in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 12

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

15% more capital invested

Capital invested by funds: $42.2M → $48.7M (+$6.45M)

11% more funds holding

Funds holding: 7583 (+8)

1.81% more ownership

Funds ownership: 14.24%16.06% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

88% less call options, than puts

Call options by funds: $44K | Put options by funds: $356K

Holders
83
Holders Change
+8
Holders Change %
+10.67%
% of All Funds
1.32%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
38
Reduced
12
Closed
8
Calls
$44K
Puts
$356K
Net Calls
-$312K
Net Calls Change
-$178K

HUMA Hedge Fund Activity: Q3 2023 in Review

83 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q3 2023, worth a combined $48.7M — up 15% from $42.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new HUMA positions and 8 closed out — a net gain of 8 holders — while 38 added to existing stakes and 12 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $4.06M. The largest seller was Davidson Kempner Capital Management, exiting entirely with an estimated $1.28M sold.

  • 83 institutional investors held Humacyte (HUMA) as of Q3 2023, up from 75 in Q2 2023.
  • Funds reported $48.7M of Humacyte stock for Q3 2023, up 15% quarter-over-quarter.
  • 16 funds opened new Humacyte positions in Q3 2023 and 8 closed out, a net change of +8 holders.
  • The largest Humacyte buyer in Q3 2023 was Millennium Management, an estimated $4.06M added.
  • The largest Humacyte seller in Q3 2023 was Davidson Kempner Capital Management, an estimated $1.28M sold.

Based on aggregated 13F filings for Q3 2023.